Report Summary

Molecular Diagnostics-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Molecular Diagnostics industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole Europe and Regional Market Size of Molecular Diagnostics 2013-2017, and development forecast 2018-2023
Main market players of Molecular Diagnostics in Europe, with company and product introduction, position in the Molecular Diagnostics market
Market status and development trend of Molecular Diagnostics by types and applications
Cost and profit status of Molecular Diagnostics, and marketing status
Market growth drivers and challenges

The report segments the Europe Molecular Diagnostics market as:

Europe Molecular Diagnostics Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia

Europe Molecular Diagnostics Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Infectious Disease
Oncology
Genetics
Microbiology

Europe Molecular Diagnostics Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Laboratories

Europe Molecular Diagnostics Market: Players Segment Analysis (Company and Product introduction, Molecular Diagnostics Sales Volume, Revenue, Price and Gross Margin):
Roche Diagnostics
QIAGEN N.V.
Hologic Inc
Grifols
Abbott Laboratories
Siemens Healthcare
Becton, Dickinson
Beckman Coulter
bioMérieux SA
Cepheid

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.